What Is On the Horizon for the Diagnosis and Treatment of SCLC and Large Cell Neuroendocrine Cancer?

What Is On the Horizon for the Diagnosis and Treatment of SCLC and Large Cell Neuroendocrine Cancer?

SCLC is a high-grade neuroendocrine malignancy associated with poor prognosis, comprising 15% of lung cancer cases globally. Advances in genetic profiling have revealed that SCLC is a molecularly heterogeneous disease, categorized into subtypes such as SCLC-A, SCLC-N, SCLC-P, and SCLC-I, on the basi...

Full description

Saved in:
Bibliographic Details
Main Authors: Sun Min Lim, MD, PhD, Joo Sung Gabriel Shim, MD, Hyo Sup Shim, MD, PhD, Junko Tanizaki, MD, PhD, Jorn Nutzinger, MD, Byoung Chul Cho, MD, PhD, Ross A. Soo, MBBS, PhD
Format: Article
Language:English
Published: Elsevier 2025-09-01
Series:JTO Clinical and Research Reports
Subjects:
Small cell lung cancer
Large cell neuroendocrine carcinoma
Diagnostics
Novel therapies
Online Access:http://www.sciencedirect.com/science/article/pii/S2666364325000888
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items